These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2572124)

  • 1. Impaired somatostatin response to orally administered glucose in type II diabetes entails both somatostatin-28 and -14 and is associated with deranged metabolic control.
    Gutniak M; Grill V; Roovete A; Efendic S
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):322-6. PubMed ID: 2572124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus.
    Grill V; Gutniak M; Roovete A; Efendić S
    J Clin Endocrinol Metab; 1984 Aug; 59(2):293-7. PubMed ID: 6145723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of plasma somatostatin-like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subjects and patients with impaired glucose tolerance.
    Itoh M; Hirooka Y; Nihei N
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):468-74. PubMed ID: 6140806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose intolerance in thyrotoxicosis roles of insulin, glucagon and somatostatin.
    Lam KS; Yeung RT; Ho PW; Lam SK
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):228-34. PubMed ID: 2881418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
    Basu R; Basu A; Nielsen M; Shah P; Rizza RA
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
    Bruttomesso D; Pianta A; Mari A; Valerio A; Marescotti MC; Avogaro A; Tiengo A; Del Prato S
    Diabetes; 1999 Jan; 48(1):99-105. PubMed ID: 9892228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
    Gutniak M; Grill V; Wiechel KL; Efendić S
    Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.
    Craft S; Asthana S; Newcomer JW; Wilkinson CW; Matos IT; Baker LD; Cherrier M; Lofgreen C; Latendresse S; Petrova A; Plymate S; Raskind M; Grimwood K; Veith RC
    Arch Gen Psychiatry; 1999 Dec; 56(12):1135-40. PubMed ID: 10591291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
    Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
    Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men.
    D'Alessio DA; Ensinck JW
    Diabetes; 1990 Oct; 39(10):1198-202. PubMed ID: 1976558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose flux in controlled hyperglycaemia before and after oral glucose ingestion in men with mild type 2 diabetes.
    Rigalleau V; Beauvieux MC; Gallis JL; Gin H; Schneiter P; Tappy L
    Diabetes Metab; 2010 Jun; 36(3):234-9. PubMed ID: 20303815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating somatostatin after oral glucose in hypothyroidism.
    Kung AW; Lam KS; Pun KK; Wang C; Yeung RT
    J Endocrinol Invest; 1990 May; 13(5):403-6. PubMed ID: 1974268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
    Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
    Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of insulin response to oral glucose load after acute and chronic glycemic control in type 2 diabetic subjects.
    Hidaka H; Furusawa S; Kosugi K; Harano Y; Shigeta Y
    Horm Metab Res; 1987 Mar; 19(3):122-4. PubMed ID: 3552918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.